Screener
Eterna Therapeutics ERNA Q1 2026 earnings
Reported May 11, 2026 · After market close
EPS-$6.95Miss by $5.00
EPS estimate-$1.95
Next report
Nov 6, 2026 (In 4 days)EPS estimate-$3.84
Versus estimates
Diluted EPS
Q2 2026-$3.40Miss by $0.10
Q1 2026-$6.95Miss by $5.00
Q4 2025-$0.01Q3 2025-$0.15Q2 2025-$0.61Q1 2025-$2.25FAQ
- When did Eterna Therapeutics report Q1 2026 earnings?
- Eterna Therapeutics (ERNA) reported Q1 2026 earnings on May 11, 2026 after market close.
- What were Eterna Therapeutics's Q1 2026 revenue and EPS?
- Eterna Therapeutics reported eps of $-6.95 for Q1 2026.
- Did Eterna Therapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-1.95 by $5.00.
- How did Eterna Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 208.9% from $-2.25.
- Where can I find Eterna Therapeutics's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-022276) directly on SEC EDGAR. The filing index links above go to sec.gov.
